Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

November 30, 2008

Conditions
Bladder Cancer
Interventions
DIETARY_SUPPLEMENT

niacinamide

DRUG

carbogen

RADIATION

radiation therapy

Trial Locations (14)

BN2 5BF

Sussex Cancer Centre at Royal Sussex County Hospital, Brighton

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CT2 3NG

Kent and Canterbury Hospital, Canterbury

DE1 2QY

Derbyshire Royal Infirmary, Derby

IP4 5PD

Ipswich Hospital NHS Trust, Ipswich

LS16 6QB

Cookridge Hospital at Leeds Teaching Hospital NHS Trust, Leeds

M20 4BX

Christie Hospital NHS Trust, Manchester

CH63 4JY

Clatterbridge Centre for Oncology NHS Trust, Merseyside

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

NG5 1PB

Nottingham City Hospital NHS Trust, Nottingham

RM7 OBE

Oldchurch Hospital, Romford

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

All Listed Sponsors
lead

Mount Vernon Cancer Centre at Mount Vernon Hospital

OTHER

NCT00033436 - Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | Biotech Hunter | Biotech Hunter